Soiken Holdings Inc. (TYO:2385)

Japan · Delayed Price · Currency is JPY

215.00

+2.00 (0.94%)

Aug 6, 2026, 12:33 PM JST

32.72% (1Y)

Market Cap	5.57B +31.5%
Revenue (ttm)	4.40B -11.9%
Net Income	184.00M
EPS	7.03
Shares Out	26.16M
PE Ratio	30.28
Forward PE	n/a
Dividend	10.00 (4.67%)
Ex-Dividend Date	Jun 29, 2026

Volume	28,100
Open	213.00
Previous Close	213.00
Day's Range	213.00 - 216.00
52-Week Range	164.00 - 325.00
Beta	0.13
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 12, 2026

About Soiken Holdings

Soiken Holdings Inc. engages in the development of biomarkers in Japan. It is involved in the development and sale of cosmetics and dietary supplements comprising imidapeptides; licensing and development of biomarker technology; provision of marketing research and post-marketing surveys for dietary supplements; and research, development, and sale of functional materials, such as lactoferrin, as well as pharmaceutical products from ascochlorin derivatives. The company also provides clinical evaluation tests for foodstuffs using biomarker technol... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 1994

Employees 49

Stock Exchange Tokyo Stock Exchange

Ticker Symbol 2385

Full Company Profile

Financial Performance

In fiscal year 2025, Soiken Holdings's revenue was 4.85 billion, a decrease of -6.01% compared to the previous year's 5.16 billion. Losses were -210.00 million, -68.28% less than in 2024.

Financial Statements